Cavitation Technologies, Inc. (CVAT) Has Successfully Completed New LOW PRESSURE REACTOR (LPN)

CHATSWORTH, CA / ACCESSWIRE / February 9, 2017 / Cavitation Technologies, Inc. (OTCQB: CVAT; Berlin, WTC) announced today that it has successfully completed design and testing of its new CaviTune Super Mixer, based on low pressure cavitation (LPN).

This patent-pending technology, USPTO # 15/375,809, “Variable Flow-Through Device,” relates to cavitation based mixing and is designed for preparing mixtures, solutions, emulsions, and dispersions with the particle sizes that can be smaller than one micron, and with the added functionality of being able to operate at low pressure.

LPN is based on cavitation of fluids and fluidic mixtures though the controlled formation of cavitation bubbles and uses the energy released upon the implosion of these bubbles to alter said fluids. The device effectively modifies fluids composed of different compounds by using the implosion energy of cavitation bubbles to improve the homogeny, viscosity, and/or other physical characteristics of the fluids. The result of this process is upgraded or altered products of higher value.

This leading edge technology is designed to achieve improved performance over conventional methods and will cover a wide range of applications where low pressure processing of large volumes of fluids is required. Industries where this will be applicable include food and beverages, water, pharmaceutical and medical cannabis, coatings, fuels and chemical processing.

CTI has identified and established several multi-channel relationships for commercial testing and distribution of the LPN systems and anticipates wide acceptance of this technology. Upon completion of the system trial phase, the company expects other distribution agreements to follow in the near future.

Mr. Roman Gordon, CTI’s Global Technology Manager, stated: “We remain the leader in development of high pressure hydro-dynamic cavitation Nano Reactor ™ systems that are currently distributed internationally through our strategic partner, Desmet Ballestra Group, and now we have added an additional line of products implementing innovative technology LPN to address various needs of customers worldwide.”

About CTi

Founded in 2007, the company designs and manufactures state-of-the-art, flow-through, devices and systems, as well as develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algae oil extraction, alcoholic beverage enhancement, and water treatment. As an add-on to its existing neutralization systems, the company’s patented Nano Reactor ® allows refiners to significantly reduce both processing costs and environmental impact, while also increasing yield (http://www.ctinanotech.com/).

About Desmet Ballestra Group

The Desmet Ballestra Group provides engineering and supply of plants and equipment for the following industries worldwide:

  • Oils and Fats and Animal Feed
  • Detergents, Surfactants and related Chemicals
  • Oleochemical and Biodiesel

Desmet Ballestra’s R&D Team is composed of professionals specialized in Oils and Fats, oleochemicals and chemical processes, using the most comprehensive set of technological resources and equipment. Controlled by Financière DSBG, a holding company based in Paris, France, the Desmet Ballestra Group is present in all major market areas of the world through its integrated business units located in Northern and Central America (USA, Mexico), South America (Argentina, Brazil, Colombia), Asia & Far East (PR China, Singapore, Malaysia), India, and Europe (Belgium, Turkey, Russia, Spain).

Forward-Looking Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases forward-looking statements can be identified by terminology such as “may,” “should,” “potential,” “continue,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” and similar expressions, and include statements regarding the anticipated installation and the timing of the installation, our intent to continue to focus on research and development, marketing and sales of our unique technology, our belief that our company is positioned for accelerated growth and the expected efforts to be made to enhance our shareholder’s value. These forward-looking statements are based largely on the Company’s expectations and are subject to a number of risks and uncertainties, certain of which are beyond the Company’s control. Actual results could differ materially from these forward looking statements as a result of a variety of factors including, among others, the state of the economy, the competitive environment and our ability to perform the installation as anticipated and other factors described in our most recent Form 10-K and our other filings with the SEC, including subsequent periodic reports on Forms 10-Q and 8-K. In light of these risks and uncertainties there can be no assurances that the forward-looking statements contained in this press release will in fact transpire or prove to be accurate. The information in this release is provided only as of the date of this release, and we undertake no obligation to update any forward-looking statements contained in this release on account of new information, future events, or otherwise, except as required by law.

Cavitation Technologies, Inc.

Contact:

Investor Relations
Jessica Steidinger
Jessica@ctinanotech.com
Phone (818) 718-0905

SOURCE: Cavitation Technologies, Inc.